GUEVA
GUEVA, licence 80113968: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Vietnam GMP Health Joint Stock Company
- NPN or DIN-HM
- 80113968
- Status
- Active licence
- Licence date
- 4 November 2021
- Revision date
- 25 September 2026
- Form
- Comprimé, enrobé par pellicule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 5,6-Dihydro-9,10-diméthoxybenzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium Source : Coptis chinensis - Rhizome | 10.0 mg | Not calculated |
| 5,6-Dihydro-9,10-diméthoxybenzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium Source : Berberine hydrochloride | 10.0 mg | Not calculated |
| Niacine Source : Niacinamide | 7.0 mg | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium, Phosphate dicalcique, Povidone K-30, Oxyde de fer (Fe2O3), Cellulose microcristalline, Jaune FD&C n° 6, Dioxyde de titane, Hydroxypropyl méthylcellulose, Caramel, Rouge D&C no. 27, Crospovidone, Poly(éthylène glycol), Triacétine, Stéarate de magnésium, Croscarmellose de sodium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18.0 Année(s) | 3.0 Comprimé | 2.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps in energy metabolism and tissue formation. Helps normal growth and development. Could be a complement to a healthy lifestyle that incorporates a calorie-reduced diet and regular physical activity for individuals involved in a weight management program. Helps lower blood total (and LDL) cholesterol. Helps maintain healthy cholesterol levels.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80113968
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.